Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Novel P53 mutations detected by FAMA in colorectal cancers
F De Galitiis, K Cannita, A Tessitore, et al.
British Journal of Cancer
|
May 22, 2008
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study
V Adamo, V Lorusso, R Rossello, et al.
Oncology Letters
|
June 29, 2012
Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas in Sicily: A multicentre retrospective study in relation to trastuzumab treatment
A Ieni, G Giuffrè, S Lanzafame, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 12, 2008
Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients
B Vincenzi, D Santini, G Perrone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2002
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer
G V Scagliotti, F De Marinis, M Rinaldi, et al.
Breast Cancer Research and Treatment
|
August 15, 2013
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study
M Campiglio, R Bufalino, M Sasso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study
L Crinò, G Scagliotti, M Marangolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
L Crinò, G V Scagliotti, S Ricci, et al.
British Journal of Cancer
|
May 27, 2004
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
M Di Maio, C Gridelli, C Gallo, et al.
British Journal of Cancer
|
January 26, 2005
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer
S De Placido, M De Laurentiis, M De Lena, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Novel P53 mutations detected by FAMA in colorectal cancers
F De Galitiis, K Cannita, A Tessitore, et al.
British Journal of Cancer
|
May 22, 2008
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study
V Adamo, V Lorusso, R Rossello, et al.
Oncology Letters
|
June 29, 2012
Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas in Sicily: A multicentre retrospective study in relation to trastuzumab treatment
A Ieni, G Giuffrè, S Lanzafame, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 12, 2008
Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients
B Vincenzi, D Santini, G Perrone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2002
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer
G V Scagliotti, F De Marinis, M Rinaldi, et al.
Breast Cancer Research and Treatment
|
August 15, 2013
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study
M Campiglio, R Bufalino, M Sasso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study
L Crinò, G Scagliotti, M Marangolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
L Crinò, G V Scagliotti, S Ricci, et al.
British Journal of Cancer
|
May 27, 2004
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
M Di Maio, C Gridelli, C Gallo, et al.
British Journal of Cancer
|
January 26, 2005
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer
S De Placido, M De Laurentiis, M De Lena, et al.
Page
of 8